← Evidence map

TrialPediatric blood & cancer2018

Dose-escalation is needed for gross disease in high-risk neuroblastoma.

Dana L Casey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29469198